CN115385960A - Preparation method and application of oxaspiro compound with large steric hindrance - Google Patents
Preparation method and application of oxaspiro compound with large steric hindrance Download PDFInfo
- Publication number
- CN115385960A CN115385960A CN202110565725.5A CN202110565725A CN115385960A CN 115385960 A CN115385960 A CN 115385960A CN 202110565725 A CN202110565725 A CN 202110565725A CN 115385960 A CN115385960 A CN 115385960A
- Authority
- CN
- China
- Prior art keywords
- acid
- reaction
- oxaspiro
- tert
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000008628 oxaspiro compounds Chemical class 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 23
- 238000006243 chemical reaction Methods 0.000 claims abstract description 63
- 239000003446 ligand Substances 0.000 claims abstract description 34
- -1 diphosphine compound Chemical class 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000007037 hydroformylation reaction Methods 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000010948 rhodium Substances 0.000 claims abstract description 12
- 229910052703 rhodium Inorganic materials 0.000 claims abstract description 11
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims abstract description 8
- 238000010917 Friedel-Crafts cyclization Methods 0.000 claims abstract description 7
- 150000001336 alkenes Chemical class 0.000 claims abstract description 7
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical class PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000005804 alkylation reaction Methods 0.000 claims abstract description 6
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 6
- 238000007256 debromination reaction Methods 0.000 claims abstract description 4
- 238000005886 esterification reaction Methods 0.000 claims abstract description 4
- 230000003647 oxidation Effects 0.000 claims abstract description 4
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- GUOGSANXPRRCMX-UHFFFAOYSA-N 1-(3-methoxyphenoxy)propan-2-ol Chemical compound COC1=CC=CC(OCC(C)O)=C1 GUOGSANXPRRCMX-UHFFFAOYSA-N 0.000 claims description 17
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- IOHPALNQKUJFNZ-UHFFFAOYSA-N 1-(3-methoxyphenoxy)propan-2-one Chemical compound COC1=CC=CC(OCC(C)=O)=C1 IOHPALNQKUJFNZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000007810 chemical reaction solvent Substances 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 10
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 9
- 230000003197 catalytic effect Effects 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000012024 dehydrating agents Substances 0.000 claims description 9
- 239000007789 gas Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 230000035484 reaction time Effects 0.000 claims description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 229940051269 1,3-dichloro-2-propanol Drugs 0.000 claims description 7
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 claims description 7
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 5
- FHJYNPLJBTVKBO-UHFFFAOYSA-N 2,2-bis(chloromethyl)-1,3-dioxolane Chemical compound ClCC1(CCl)OCCO1 FHJYNPLJBTVKBO-UHFFFAOYSA-N 0.000 claims description 5
- HLCYOXANCYSPFB-UHFFFAOYSA-N 2,4-ditert-butyl-5-methoxyphenol Chemical compound COC1=CC(O)=C(C(C)(C)C)C=C1C(C)(C)C HLCYOXANCYSPFB-UHFFFAOYSA-N 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 5
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 235000010233 benzoic acid Nutrition 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 229940117975 chromium trioxide Drugs 0.000 claims description 5
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims description 5
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 claims description 5
- 239000012043 crude product Substances 0.000 claims description 5
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 5
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical compound C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 claims description 5
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002841 Lewis acid Substances 0.000 claims description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 claims description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- DQTRYXANLKJLPK-UHFFFAOYSA-N chlorophosphonous acid Chemical group OP(O)Cl DQTRYXANLKJLPK-UHFFFAOYSA-N 0.000 claims description 4
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 claims description 4
- IAQRGUVFOMOMEM-ARJAWSKDSA-N cis-but-2-ene Chemical compound C\C=C/C IAQRGUVFOMOMEM-ARJAWSKDSA-N 0.000 claims description 4
- 230000001335 demethylating effect Effects 0.000 claims description 4
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 claims description 4
- DNKPFCQEGBJJTE-UHFFFAOYSA-N diiodohydroxypropane Chemical compound ICC(O)CI DNKPFCQEGBJJTE-UHFFFAOYSA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 150000007517 lewis acids Chemical class 0.000 claims description 4
- 229910044991 metal oxide Inorganic materials 0.000 claims description 4
- 150000004706 metal oxides Chemical class 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 4
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 claims description 4
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 4
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N binaphthyl group Chemical group C1(=CC=CC2=CC=CC=C12)C1=CC=CC2=CC=CC=C12 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 229960001701 chloroform Drugs 0.000 claims description 3
- 230000000536 complexating effect Effects 0.000 claims description 3
- 230000002140 halogenating effect Effects 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 239000001282 iso-butane Substances 0.000 claims description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 229910052723 transition metal Inorganic materials 0.000 claims description 3
- 150000003624 transition metals Chemical class 0.000 claims description 3
- KIUPCUCGVCGPPA-UHFFFAOYSA-N (5-methyl-2-propan-2-ylcyclohexyl) carbonochloridate Chemical compound CC(C)C1CCC(C)CC1OC(Cl)=O KIUPCUCGVCGPPA-UHFFFAOYSA-N 0.000 claims description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 2
- KIHQZLPHVZKELA-UHFFFAOYSA-N 1,3-dibromopropan-2-ol Chemical compound BrCC(O)CBr KIHQZLPHVZKELA-UHFFFAOYSA-N 0.000 claims description 2
- PVDLUGWWIOGCNH-UHFFFAOYSA-N 1,3-difluoro-2-propanol Chemical compound FCC(O)CF PVDLUGWWIOGCNH-UHFFFAOYSA-N 0.000 claims description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 claims description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 2
- MOPJSMIEGALASX-UHFFFAOYSA-N 2,2-bis(bromomethyl)-1,3-dioxolane Chemical compound BrCC1(CBr)OCCO1 MOPJSMIEGALASX-UHFFFAOYSA-N 0.000 claims description 2
- JQNSRTOLFNUADH-UHFFFAOYSA-N 2,2-bis(fluoromethyl)-1,3-dioxolane Chemical compound FCC1(CF)OCCO1 JQNSRTOLFNUADH-UHFFFAOYSA-N 0.000 claims description 2
- MRQZYSCYMGQVTL-UHFFFAOYSA-N 2,2-bis(iodomethyl)-1,3-dioxolane Chemical compound ICC1(CI)OCCO1 MRQZYSCYMGQVTL-UHFFFAOYSA-N 0.000 claims description 2
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 claims description 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 230000002152 alkylating effect Effects 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940077239 chlorous acid Drugs 0.000 claims description 2
- 229960005215 dichloroacetic acid Drugs 0.000 claims description 2
- 229940117389 dichlorobenzene Drugs 0.000 claims description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims description 2
- UQSQSQZYBQSBJZ-UHFFFAOYSA-N fluorosulfonic acid Chemical compound OS(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 229940013688 formic acid Drugs 0.000 claims description 2
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- 238000005658 halogenation reaction Methods 0.000 claims description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 2
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 229940078552 o-xylene Drugs 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 229940116315 oxalic acid Drugs 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- 229940005657 pyrophosphoric acid Drugs 0.000 claims description 2
- 229940107700 pyruvic acid Drugs 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- RKSOPLXZQNSWAS-UHFFFAOYSA-N tert-butyl bromide Chemical compound CC(C)(C)Br RKSOPLXZQNSWAS-UHFFFAOYSA-N 0.000 claims description 2
- NBRKLOOSMBRFMH-UHFFFAOYSA-N tert-butyl chloride Chemical compound CC(C)(C)Cl NBRKLOOSMBRFMH-UHFFFAOYSA-N 0.000 claims description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 2
- 229940005605 valeric acid Drugs 0.000 claims description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 2
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- 239000011261 inert gas Substances 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000003208 petroleum Substances 0.000 claims 1
- 239000003444 phase transfer catalyst Substances 0.000 claims 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- QJDUDPQVDAASMV-UHFFFAOYSA-M sodium;ethanethiolate Chemical compound [Na+].CC[S-] QJDUDPQVDAASMV-UHFFFAOYSA-M 0.000 claims 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N pentanal Chemical compound CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 8
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 abstract description 7
- 230000009257 reactivity Effects 0.000 abstract description 2
- 230000029936 alkylation Effects 0.000 abstract 2
- 238000010520 demethylation reaction Methods 0.000 abstract 2
- 230000031709 bromination Effects 0.000 abstract 1
- 238000005893 bromination reaction Methods 0.000 abstract 1
- 230000017858 demethylation Effects 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 230000007704 transition Effects 0.000 abstract 1
- 238000005070 sampling Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 5
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- BYGQBDHUGHBGMD-UHFFFAOYSA-N 2-methylbutanal Chemical compound CCC(C)C=O BYGQBDHUGHBGMD-UHFFFAOYSA-N 0.000 description 4
- KZRJKMZQXATVEB-UHFFFAOYSA-N chlorophosphinous acid Chemical compound OPCl KZRJKMZQXATVEB-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000001893 (2R)-2-methylbutanal Substances 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000012649 demethylating agent Substances 0.000 description 2
- 238000005485 electric heating Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- YLQLIQIAXYRMDL-UHFFFAOYSA-N propylheptyl alcohol Chemical compound CCCCCC(CO)CCC YLQLIQIAXYRMDL-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 125000003003 spiro group Chemical group 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PPTXVXKCQZKFBN-UHFFFAOYSA-N (S)-(-)-1,1'-Bi-2-naphthol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=C(O)C=CC2=C1 PPTXVXKCQZKFBN-UHFFFAOYSA-N 0.000 description 1
- BBQFRSVTZXRYFA-UHFFFAOYSA-N 1,1'-biphenyl hydroxyphosphanyloxyphosphinous acid Chemical compound P(O)OPO.C1(=CC=CC=C1)C1=CC=CC=C1 BBQFRSVTZXRYFA-UHFFFAOYSA-N 0.000 description 1
- AUHOOONALCXGNL-UHFFFAOYSA-N 1,5-bis(3-hydroxyphenyl)pentan-3-one Chemical compound OC1=CC=CC(CCC(=O)CCC=2C=C(O)C=CC=2)=C1 AUHOOONALCXGNL-UHFFFAOYSA-N 0.000 description 1
- JQSGJKMKNAOSMA-UHFFFAOYSA-N 1,5-bis(5-hydroxy-2-methylphenyl)pentan-3-one Chemical compound Cc1ccc(O)cc1CCC(=O)CCc1cc(O)ccc1C JQSGJKMKNAOSMA-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000001361 allenes Chemical class 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 150000005347 biaryls Chemical group 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- GGRQQHADVSXBQN-FGSKAQBVSA-N carbon monoxide;(z)-4-hydroxypent-3-en-2-one;rhodium Chemical compound [Rh].[O+]#[C-].[O+]#[C-].C\C(O)=C\C(C)=O GGRQQHADVSXBQN-FGSKAQBVSA-N 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- USJRLGNYCQWLPF-UHFFFAOYSA-N chlorophosphane Chemical compound ClP USJRLGNYCQWLPF-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- QPUSANCBJDDXSA-UHFFFAOYSA-N ethanethiol;sodium Chemical compound [Na].CCS QPUSANCBJDDXSA-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000006138 lithiation reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- XRBCRPZXSCBRTK-UHFFFAOYSA-N phosphonous acid Chemical compound OPO XRBCRPZXSCBRTK-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010512 small scale reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/2208—Oxygen, e.g. acetylacetonates
- B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
- B01J31/2247—At least one oxygen and one phosphorous atom present as complexing atoms in an at least bidentate or bridging ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
- C07C45/50—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
- C07C45/505—Asymmetric hydroformylation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/32—Addition reactions to C=C or C-C triple bonds
- B01J2231/321—Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2523/00—Constitutive chemical elements of heterogeneous catalysts
- B01J2523/80—Constitutive chemical elements of heterogeneous catalysts of Group VIII of the Periodic Table
- B01J2523/82—Metals of the platinum group
- B01J2523/822—Rhodium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a large steric hindrance oxaspiro compound, which is as follows: 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -biphenol and diphosphine compounds thereof. The method takes 3-methoxyphenol as a starting material and can carry out 7 steps of reactions, namely: nucleophilic substitution, oxidation, bromination, friedel-crafts cyclization, debromination, demethylation and alkylation; or through 4 (or 5) steps of reaction, namely: alkylation, nucleophilic substitution, (oxidation), friedel-crafts cyclization and demethylation reaction to obtain corresponding racemic oxaspiro diphenol, and esterification is carried out to obtain the high steric hindrance oxaspiro diphosphonite compound. The oxaspiro diphosphine compound has a structure shown as a general formula I, and a racemate thereof and transition goldThe formed ligand has excellent reactivity, selectivity and stability in olefin hydroformylation. Meanwhile, the invention discloses a hydroformylation reaction of the rhodium/oxaspiro diphosphine ligand by taking mixed C4 as a raw material to prepare valeraldehyde.
Description
Technical Field
The invention relates to an oxaspiro diphenol skeleton 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -diphenol and a preparation method and application of diphosphonite compounds thereof.
Background
The axisymmetric organic compound is always a research hotspot in the field of asymmetric catalysis, and the axisymmetric compound has wide application in the fields of biological medicine, industrial catalysis, functional materials and the like. Biaryl ligands such as BINOL and BINAP which have been successfully commercialized recently have been widely used.
In 1999 Birman et al, starting from acetone and 3-methoxybenzaldehyde, reacted in six steps to give racemic spiroindandiol ((. + -.) -SPINOL). The diastereomers of the diphenols and menthyl chloroformate may be separated by column chromatography to provide optically pure (R) - (+) -SPINOL and (S) - (-) -SPINOL. Similar synthetic routes and resolution methods are also reported in US20130135574A1, CN 1055003542A. On the basis, zhou Jilin and the like of the university of south Kekai report more practical resolution methods in 2002, and the optically pure spiroindane diphenol can be obtained by utilizing the characteristic that benzyl cinchonidine chloride and one enantiomer are easy to form an inclusion compound through simple steps of refluxing, cooling, crystallizing, filtering, acidifying and the like. 2016, tan Bin et al reported asymmetric synthesis of SPINOL catalyzed by chiral phosphonic acid, directly from 1,5-bis (5-hydroxy-2-methylphenyl) -3-pentanone to (S) -4,4' -dimethyl-7,7 ' -dihydroxy-1,1 ' -spiroindane (yield 97%, ee value 90%). It is worth mentioning that the ligands used by them are phosphonic acids with a chiral SPINOL backbone. In addition, CN109761774A studied a Friedel-crafts cyclization from 1,5-bis (3-hydroxyphenyl) -3-pentanone to racemic SPINOL method, which is the first report on the cyclization synthesis of 1,1 '-spiroindene-7,7' -biphenol without a spacer at the para-hydroxyl position.
Hydroformylation has found a very large industrial application since its discovery in 1938 by professor Otto Roelen. The production and consumption of butyraldehyde by hydroformylation of propylene as a raw material and production of butanol and octanol (mainly used for producing dioctyl phthalate (DOP)) by condensation hydrogenation are the largest, and the domestic annual demand is over 300 million tons. Because DOP is small and volatile in molecular weight, the global trend is to use higher molecular weight, low volatility and more stable plasticizers based on environmental and health safety considerations. And 2-propylheptanol (2-PH) is prepared by condensation hydrogenation after hydroformylation of butene to produce valeraldehyde, and the DPHP plasticizer produced from 2-PH can well solve the worry of DOP in the aspects of environmental protection, health and safety. To date, the united states and countries of the european union have begun to replace DOP with DPHP, a trend that has begun to impact asian markets.
The mixed carbon four hydroformylation method is the most economical and direct route which is generally accepted in the production process of valeraldehyde reported at present. A catalytic system consisting of biphenyl diphosphonite type ligands (Biphephos) and rhodium developed by United states carbonization (Toho chemical) can effectively carry out hydroformylation reaction on 2-butene in mixed C4 and can obtain high normal-iso ratio. Bisphosphonite ligands such as those proposed in US4668651, US4769498, US4148830, CN86106770 and CN86106811 can be made up to a normality ratio of 26. Whereas the fourth generation bisphosphonite catalyzed hydroformylation production process based on Biphephos has been industrialized.
Bidentate and multidentate phosphonite/phosphoramidite ligands with biphenyl, binaphthyl and anthracene skeletons (e.g. Biphephos, anthraneetriol-based triphosphates) are widely reported and patented by foreign large chemical companies such as basf, dow chemical and winning and some research groups, while spiro bisphosphinite/phosphoramidite ligands are very rarely reported in hydroformylation reactions. In 2012, ding Kuilin et al reported that a series of spiroketal diphosphinimide ligands showed excellent conversion (90%) and normal to iso ratio (l/b = 174.4) in hydroformylation of 1-hexene and other terminal alkenes, but only conversion less than 15% in catalyzing hydroformylation of internal alkenes (e.g., trans-2-butene). Therefore, the development of a novel spiro diphosphine ligand with higher efficiency, selectivity and stability has important significance and industrial application value.
The novel preparation method of the high steric hindrance oxaspiro diphenol and the diphosphonite ligand thereof, which is developed by the invention, has the advantages of being capable of reacting from the initial raw material to the racemized O-SPINOL in four steps at the shortest time, being easy to synthesize, suitable for amplified synthesis, free of expensive reagents and metal catalysts, capable of realizing industrialization and the like. The method has the characteristics of simple process route, high yield, avoidance of violent and dangerous experimental conditions, and recycling of reagents and raw materials. In addition, the novel high-steric-hindrance oxaspiro diphosphonite ligand (racemate) can be used for catalyzing hydroformylation reaction which takes cheap ether late carbon four or MTO carbon four as raw materials.
Disclosure of Invention
The embodiment of the invention aims to provide a preparation method and application of a large-steric-hindrance oxaspiro-ring compound.
The embodiment of the invention is realized by that the structure of the large steric hindrance oxaspiro diphenol and diphosphonite compound thereof is shown as the general formula I:
wherein, the structure of the general formula I and the derivative thereof is shown as follows:
the oxaspiro diphosphonite compound is prepared by reacting 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -diphenol serving as a raw material with chlorophosphinite containing aryl or cyclic aryl structure under the action of an organic solvent and n-butyl lithium or triethylamine; the oxaspiro diphosphonite ligand is one of L1-L31.
Drawings
FIG. 1 is a schematic view of a batch olefin pilot plant used in comparative examples of the present invention;
FIG. 2, of the ligand Compound L4 of the present invention 1 H NMR(600MHz,CDCl 3 ) A schematic diagram;
FIG. 3, of the ligand Compound L4 of the present invention 31 PNMR(243MHz,CDCl 3 ) Schematic representation.
Detailed Description
The present invention will be described in detail with reference to the accompanying drawings and examples, so that the objects, technical solutions and advantages of the present invention will be more clearly understood. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The invention discloses a synthetic route of three kinds of oxaspiro compounds with large steric hindrance, which is characterized in that 3-methoxyphenol is used for reacting for 4 to 7 steps to obtain oxaspiro diphenol with large steric hindrance, and the oxaspiro diphenol and chlorophosphites are subjected to esterification reaction to obtain an oxaspiro diphosphonite ligand.
Specifically, the synthesis method of the present invention is specifically described as follows:
in some embodiments, 3-methoxyphenol undergoes a nucleophilic substitution reaction with 1,3-dichloro-2-propanol to give 1,5-bis (3-methoxyphenoxy) -2-propanol (2); under the catalysis of protonic acid or Lewis acid, isobutene and protons are added to generate tert-butyl carbonium ions, and the tert-butyl carbonium ions are further subjected to alkylation reaction with a benzene ring on 3-methoxyphenol to obtain 2,4-di-tert-butyl-5-methoxyphenol (2 a or 2 c); 2,4-di-tert-butyl-5-methoxyphenol and 1,3-dichloro-2-propanol or 2,2-bis (chloromethyl) -1,3-dioxolane are subjected to nucleophilic substitution reaction to obtain 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -2-propanol (3 a) or 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -2-propyldioxolane (3 c).
In some embodiments, the nucleophilic substitution reaction using a halogenating agent other than 1,3-dichloro-2-propanol or 2,2-bis (chloromethyl) -1,3-dioxolane can also be: 1,3-difluoro-2-propanol, 1,3-dibromo-2-propanol, 1,3-diiodo-2-propanol, epichlorohydrin; or 2,2-bis (fluoromethyl) -1,3-dioxolane, 2,2-bis (bromomethyl) -1,3-dioxolane, 2,2-bis (iodomethyl) -1,3-dioxolane.
In some embodiments, the protic or lewis acid used in the alkylation reaction is one or more of an organic acid or an inorganic acid, such as: formic acid, acetic acid, oxalic acid, dichloroacetic acid, trifluoroacetic acid, propionic acid, malonic acid, pyruvic acid, butyric acid, valeric acid, caproic acid, adipic acid, benzoic acid, p-nitrobenzoic acid, terephthalic acid, benzenesulfonic acid, fluorosulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and the like; inorganic acids such as: hydrobromic acid, hydrochloric acid, hydrofluoric acid, sulfurous acid, sulfuric acid, perchloric acid, phosphonic acid, pyrophosphoric acid, nitric acid, nitrous acid, chromic acid, fluoroantimonic acid, and the like; the alkylating reagent is any one of bromo-tert-butane, chloro-tert-butane, isobutene and tert-butanol; the reaction temperature is 80-140 ℃, and the reaction solvent is any one of benzene, toluene, p-xylene, o-xylene, chlorobenzene or dichlorobenzene.
In some embodiments, catalytic oxidation of intermediate 2 or 3a with chromium trioxide affords 1,5-bis (3-methoxyphenoxy) -acetone (3) or 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -acetone (4 a).
In some embodiments, the metal oxide used for the oxidation reaction is any one of chromium trioxide, chromic acid, potassium dichromate, and sodium dichromate; the acid solution can be any one of concentrated sulfuric acid, phosphonic acid, hexafluorophosphonic acid, hypochlorous acid, chlorous acid, glacial acetic acid and peroxyacetic acid; the dosage of the metal oxide is 0.05 to 1 equivalent, the reaction solvent is acetone or water or a mixed solvent thereof, the proportion of the mixed solvent is between 50 and 70, and the reaction temperature is between 25 and 45 ℃.
In some more preferred embodiments, intermediate 3 is halogenated with bromine or N-bromosuccinimide to provide 1,5-bis (2-bromo-3-methoxyphenoxy) -acetone (4); under the action of a dehydrating agent, the intermediate 4 or 4a or 3c is subjected to Friedel-crafts cyclization to obtain 4,4' -dibromo-7,7 ' -dimethoxy-1,1 ' -spirodihydrobenzofuran (5) or 4,4',6,6' -tetra-tert-butyl-7,7 ' -dimethoxy-1,1 ' -spirodihydrobenzofuran (5 a or 4 c).
In some embodiments, the amount of bromine or N-bromosuccinimide used in the halogenation reaction is 1 to 10 equivalents, pyridine is 2 to 20 equivalents, the reaction temperature is-20 to 40 ℃, the reaction time is 2 to 24 hours, and the reaction solvent is organic solvent such as diethyl ether, tetrahydrofuran, 1,4-dioxane, dichloromethane, and the like.
In some embodiments, the dehydrating agent used in the friedel-crafts cyclization reaction is any one of polyphosphoric acid, concentrated sulfuric acid, acetic anhydride, methanesulfonic acid, benzoic acid, p-toluenesulfonic acid and anhydrous aluminum trichloride. The reaction solvent is any one of toluene, n-heptane, dichloromethane, trichloromethane and dichloroethane. The dosage of the dehydrating agent is 10 to 70 equivalent, the reaction temperature is 45 to 135 ℃, and the reaction time is 2 to 6 hours.
In some embodiments, intermediate 4 or 4a is cyclized under the action of a dehydrating agent to give 4,4',6,6' -tetra-tert-butyl-1,1 '-spiroindane-7,7' -biphenol (5) or 4,4 '-dimethoxy-6,6' -di-tert-butyl-1,1 '-spiroindane-7,7' -biphenol (5 a).
In some embodiments, the dehydrating agent is any one of polyphosphoric acid, concentrated sulfuric acid, acetic anhydride, methanesulfonic acid, benzoic acid, p-toluenesulfonic acid, anhydrous aluminum trichloride. The reaction solvent is any one of toluene, n-heptane, dichloromethane, trichloromethane and dichloroethane. The dosage of the dehydrating agent is 10 to 70 equivalent, the reaction temperature is 45 to 135 ℃, and the reaction time is 2 to 6 hours.
In some embodiments, intermediate 5 is debrominated with n-butyllithium to provide 7,7 '-dimethoxy-1,1' -spirodihydrobenzofuran (6), intermediate 6 or 5a or 4c is deprotected from the methyl group with a demethylating agent to provide 1,1 '-spirodihydrobenzofuran-7,7' -biphenol (7) or 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -biphenol ((rac) -O-SPINOL), and intermediate 7 is alkylated with isobutylene to provide racemic sterically hindered (rac) -O-SPINOL.
In some embodiments, the n-butyllithium is used in an amount of 2.5 to 10 equivalents in the debromination reaction, the reaction temperature is-78 to 5 ℃, the reaction time is 0.5 to 5 hours, and the reaction solvent is organic solvent such as diethyl ether, tetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether, and the like.
In some embodiments, the demethylating agent is any of boron tribromide, hydrobromic acid, aluminum trichloride, pyridine hydrochloride, sodium ethanethiol. The dosage of the demethylating reagent is 2.0 to 5 equivalent, the reaction temperature is-78 to 25 ℃, and the reaction solvent is any one of dichloromethane, dichloroethane and trichloroethane.
In some embodiments, (rac) -O-SPINOL is reacted with n-butyllithium to obtain a lithiated reaction solution; and reacting the reaction liquid after lithiation with chlorophosphinite containing aryl or cyclic aryl structure to obtain the high-steric-hindrance oxaspiro diphosphonite compound.
In some embodiments, (rac) -O-SPINOL is reacted with a mixed solution of chlorophosphinite containing aryl or cyclic aryl structures and an acid-binding agent to give the highly hindered oxaspiro bisphosphonite compound.
In some embodiments, n-butyllithium is used in an amount of 2 to 4 equivalents in the esterification reaction; the acid binding agent is any one of triethylamine, N-diisopropylethylamine and pyridine, and the dosage is 5-20 equivalent; the reaction temperature is-78-80 ℃, the reaction time is 12-48 hours, and the reaction solvent is any one of toluene, tetrahydrofuran, diethyl ether, 2-methyl tetrahydrofuran, methyl tert-butyl ether, isopropyl ether, anisole, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, butyl ether, cyclopentyl methyl ether or 1,4-dioxane.
Example 1: preparation (2) of 2,4-di-tert-butyl-5-methoxyphenol
A2L two-necked flask was charged with 1a (30.0 g, 241).7 mmol), the reaction flask was replaced with a nitrogen atmosphere, and 200ml of tetrahydrofuran and concentrated sulfuric acid (3.9 g) were added thereto at 25 ℃. Isobutene under 1.5 atmospheres is continuously introduced, and the reaction is continued for 12 hours by heating to 100 ℃. After the reaction solution was quenched with water, 300ml of water was added and extracted with ethyl acetate. The organic phase was dried over anhydrous sodium sulfate and then dried by rotary drying under reduced pressure to obtain a pale yellow solid (54.8 g) in a yield of 96%. 1 HNMR(400MHz,CDCl 3 ):δ=1.39(s,9H),1.44(s,9H),3.84(s,3H),6.32(s,1H),6.72(s,1H),7.17(s,1H)。
Example 2: preparation of 1,5-bis (3-methoxyphenoxy) -2-propanol (2), 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -2-propanol (3 a) or 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -2-propyldioxolane (3 c)
A5L two-necked flask was charged with 1 or 2a or 2c (100 g), 1,3-dichloro-2-propanol or 2,2-bis (chloromethyl) -1,3-dioxolane, potassium carbonate and dimethylformamide. The reaction was continued at 140 ℃ for 10 hours. The reaction mixture was filtered, dried over anhydrous sodium sulfate, and rotary-dried under reduced pressure to give the desired product 2 (74.8 g), or 3a (64.9 g), or 3c (62.8 g) in corresponding yields of 61%, 58%, and 52%.2: 1 H NMR(400MHz,CDCl 3 ):δ=3.54(d,1H),3.78(s,6H),4.04–4.17(m,4H),4.31(m,1H),6.42(t,2H),6.62(m,2H),6.80(m,2H),7.19(t,2H);3a: 1 H NMR(400MHz,CDCl 3 ):δ=1.37(d,36H),3.28(d,1H),3.81(s,6H),4.03–4.18(m,4H),4.27(m,1H),6.49(s,2H),7.27(s,2H);3c: 1 H NMR(400MHz,CDCl 3 ):δ=1.38(d,36H),3.84(s,6H),3.92(s,4H),4.41(s,4H),6.43(s,2H),7.25(s,2H)。
example 3: preparation of 1,5-bis (3-methoxyphenoxy) -acetone (3) or 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -acetone (4 a)
In 500mlThe round-bottomed bottle of (2) or (3 a) (30.0 g), chromium trioxide (9.0 g), concentrated sulfuric acid (7.5 ml) and 200ml of acetone were added. After stirring well, the reaction was continued at room temperature for 6 hours. The reaction mixture was filtered, washed with water, dried over anhydrous sodium sulfate, and rotary-dried under reduced pressure to give the desired product 3 (25.8 g) or 4a (27.3 g) in 87% or 91% yield. 3: 1 H NMR(400MHz,CDCl 3 ):δ=3.78(s,6H),4.97(s,4H),6.50(t,2H),6.70(m,2H),6.80(m,2H),7.20(t,2H);4a: 1 H NMR(400MHz,CDCl 3 ):δ=1.38(s,18H),1.42(s,18H),3.84(s,6H),4.99(s,4H),6.50(s,2H),7.27(s,2H)。
example 4: 8978 preparation of zxft 8978-bis (2-bromo-3-methoxyphenoxy) -acetone (4)
3 (20.0 g, 66.2mmol) was added to a 500ml two-necked flask, followed by dichloromethane (200 ml). After stirring the mixture uniformly, a 2.0mol/L solution of bromine in methylene chloride (40ml, 79.4 mmol) was added dropwise to the reaction mixture. Stirring and reacting for 4 hours after the dropwise adding is finished, filtering the reaction solution, drying the reaction solution by anhydrous sodium sulfate, performing reduced pressure spin drying to obtain a crude product, and performing flash column chromatography to obtain a target product 21.9g with the yield of 72%. 1 HNMR(400MHz,CDCl 3 ):δ=3.81(s,6H),5.02(s,4H),6.53(dd,2H),6.77(d,2H),7.52(d,2H)。
Example 5: preparation of 4,4',6,6' -tetra-tert-butyl-1,1 '-spiroindane-7,7' -biphenol (5) or 4,4 '-dimethoxy-6,6' -di-tert-butyl-1,1 '-spiroindane-7,7' -biphenol (5 a or 4 c)
In a 500ml round bottom flask, 4 (20.0g, 43.5mmol), or 4a (20.0g, 38.0mmol) or 3c (20.0g, 35.0mmol) in this order, polyphosphoric acid and methanol were added, and the mixture was heated at 60 ℃ for stirring for 6 hours. After the reaction is finished, washing with water, extracting an organic phase with ethyl acetate, drying with anhydrous sodium sulfate, performing reduced pressure rotary drying to obtain a crude product, and performing rapid dryingAnd (5) performing column chromatography separation. Recrystallization from n-hexane gave the desired product 5 (13.7 g) or 5a (12.6 g) or 4c (10.1 g) in 71%, 65% and 57% yields. 5: 1 HNMR(400MHz,CDCl 3 ) δ =3.82 (s, 6H), 4.49 (d, 2H), 4.66 (d, 2H), 6.58 (d, 2H), 7.40 (d, 2H); 5a or 4c: 1 H NMR(400MHz,CDCl 3 ):δ=1.39(s,18H),1.42(s,18H),3.77(s,6H),4.46(d,2H),4.61(d,2H),7.28(s,2H)。
example 6: preparation of 7,7 '-dimethoxy-1,1' -spirodihydrobenzofuran (6)
5 (5.0 g,11.3 mmol) and 80ml of tetrahydrofuran were charged into a dry 250ml Schlenk flask, the reaction flask was replaced with a nitrogen atmosphere, and after cooling the reaction solution to-78 ℃, 2.5M n-butyllithium (18.1ml, 4.0 eq) was added dropwise. After 1 hour of reaction, the reaction was quenched by addition of 6.0ml ethanol, washed with water, the organic phase was extracted with dichloromethane, dried over anhydrous sodium sulfate, spin-dried under reduced pressure to give a crude product, which was recrystallized from n-hexane to give 3.1g of product in 95% yield. 1 H NMR(400MHz,CDCl 3 ):δ=3.80(s,6H),4.45(d,2H),4.62(d,2H),6.64–6.74(dd,4H),7.07(t,2H)。
Example 7: preparation of 1,1 '-spirodihydrobenzofuran-7,7' -biphenol (7) or 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -biphenol ((rac) -O-SPINOL)
6 (5.0 g,17.6 mmol) or 5a (or 4 c) (5.0 g,9.8 mmol) and 100ml of methylene chloride were charged into a dry 500ml Schlenk bottle, the reaction bottle was replaced with a nitrogen atmosphere, the reaction solution was cooled to-78 ℃ and then a 2.0mol/L solution of boron tribromide in methylene chloride was added dropwise. After the addition was complete, the reaction was allowed to come to room temperature overnight. Quenching the reaction with water, diluting with dichloromethane, extracting organic phase, drying with anhydrous sodium sulfate, rotary drying under reduced pressure, and recrystallizing with n-hexane to obtain crude productTo the desired product 7 (4.2 g) or (rac) -O-SPINOL (4.3 g), corresponding yields were 94% and 92%.7: 1 H NMR(400MHz,DMSO):δ=4.50(d,2H),4.58(d,2H),6.23-6.27(m,4H),6.92(dd,2H),6.78-6.80(m,4H),7.06-7.09(m,8H);(rac)-O-SPINOL: 1 H NMR(400MHz,CDCl 3 ):δ=1.40(d,36H),4.53(d,2H),4.69(d,2H),6.75(s,2H),7.14(s,2H)。
example 8: preparation of 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -biphenol ((rac) -O-SPINOL)
7 (2.0g, 7.8mol), t-butanol (3.7g, 49.5mmol) and concentrated sulfuric acid (2.4g, 24.7mmol) were sequentially added to a 200ml three-necked flask. After the addition, the reaction flask was replaced with nitrogen atmosphere and heated to reflux for 24 hours. The solvent is dried by spinning under reduced pressure, 50ml of water is added, the organic phase is extracted by ethyl acetate, dried by anhydrous sodium sulfate and then dried by spinning under reduced pressure, and the residue is subjected to flash column chromatography to obtain 3.7g of the target product with the yield of 98 percent. 1 H NMR(400MHz,CDCl 3 ):δ=1.42(d,36H),4.54(d,2H),4.71(d,2H),6.76(s,2H),7.15(s,2H)。
Example 9: preparation of 7,7 '-bis [ (1,1' -biphenyl-2,2 '-diyl) phosphonite ] -4,4',6,6 '-tetra-tert-butyl-1,1' -spiroindane (L4)
In a dry 200ml Schlenk flask were added (rac) -O-SPINOL (2.0 g, 4.2mmol), anhydrous triethylamine (8.8ml, 63.0mmol,15.0 eq.) and 40ml of anhydrous tetrahydrofuran in that order under nitrogen. Then, after cooling the mixture to-40 ℃, adding 1,1' -dioxy phosphonium chloride (2.6g, 10.5mmol, 2.5equiv.) in 30ml of anhydrous tetrahydrofuran solution dropwise, reacting at room temperature for 24 hours after finishing dropping, concentrating the reaction solution under nitrogen atmosphere, separating the crude product by fast column chromatography, and recrystallizing with acetonitrile to obtain 2.9g of the target product with the yield of 75%. 1 HNMR(600MHz,CDCl 3 ):δ=1.18-1.24(d,36H),4.75(d,2H),4.96(d,2H),6.91–7.23(m,10H),7.27–7.30(m,4H),7.41–7.44(m,4H); 31 P NMR(243MHz,CDCl 3 ):δ=145.18。
It is to be noted here that the other oxaspirodiphosphonite ligands of the formula I, L1 to L31, can be prepared by using only different chlorophosphinite substituent derivatives.
After the target oxaspiro diphosphonite ligand is obtained, a batch type small-scale reaction device (attached figures in the specification) matched with the novel ligand is developed to simulate the hydroformylation reaction of C4 after mixing/ether in industry. We used two separate carbon four feedstocks, the first is ether rear carbon four, and the component contents are respectively (w/w): isobutane (52.1%), 1-butene (16.6%), cis-2-butene (15.3%) and trans-2-butene (16.0%); the second is MTO carbon four, the component contents are respectively (w/w): n-butane (6.0%), 1-butene (0.7%), cis-2-butene (34.7%) and trans-2-butene (58.6%).
In order to ensure that the ligand activity and the aldehyde product are not oxidized, the materials pass through a raw material pretreatment device, and besides water removal, oxygen removal, sulfur (sulfide), chlorine (halide), nitrogen-containing compounds (such as HCN) and the like, substances such as carboxylic acid, butadiene, allene, alkyne and the like which have an inhibiting effect on a rhodium catalyst in the raw materials of carbon and carbon are also removed. To test the reactivity of the novel sterically hindered oxaspiro diphosphonite Ligand in the post-ether/MTO carbon four, we tested other commercial and patent literature reported ligands in comparison under nearly identical reaction conditions, ligand 1-10 used in the following examples has the following structure:
this comparative example uses the oxaspiro bisphosphonites listed in the above examples as transition metal ligands to catalyze the hydroformylation of olefins as follows:
comparative example 1: under argon atmosphere to 200ml stainless steel high-pressure reaction kettle equipped with pressure sensor, temperature probe, online sampling port and safety relief valve, etc. is added with a certain amount of Rh (acac) (CO) 2 (0.01mmol, 2.6 mg) and a certain amount of Ligand Ligand 1-10 (0.03-0.04 mmol), adding a certain volume of toluene and internal standard substance n-decane, and stirring and complexing for 30 minutes by using a magneton to generate a catalytic complex of rhodium and the Ligand. Then, after connecting a gas pipeline and fully replacing, adding a certain proportion of liquefied ether into the reaction kettle by using a plunger pump with a metering function under the switching of a two-position four-way valve to control the concentration of the rhodium catalyst in the total solution to be about 159ppm, and uniformly stirring for 5-10 minutes at room temperature. After stirring uniformly, a mixed gas (1:1) of carbon monoxide and hydrogen is charged into the reaction device until the total pressure is 1.0MPa. The reaction kettle is heated to the required temperature (70 ℃) by a magnetic stirrer (heating kettle bottom) and an electric heating sleeve (heating kettle body), and the total pressure is kept constant at 1.0MPa by continuously supplying air during the reaction. After reacting for 2-4 hours, the reaction kettle is connected to a-40 ℃ cold sleeve for cooling, after the kettle temperature is reduced to normal temperature, an online sampling port is opened for sampling under the condition of not opening the kettle, and after the online sampling port is diluted by chromatographic grade ethyl acetate, a Gas Chromatograph (GC) is used for measuring the normal-to-iso ratio (the ratio of n-valeraldehyde to 2-methyl butyraldehyde: l: b). And after the kettle is opened, completely releasing the gas in the high-pressure reaction kettle in a fume hood, and sampling and weighing. The results are shown in Table 1.
TABLE 1
Comparative example 2: adding a certain amount of Rh (acac) (CO) into a 200ml stainless steel high-pressure reaction kettle provided with a pressure sensor, a temperature probe, an online sampling port, a safety relief valve and the like under the argon atmosphere 2 (0.01mmol, 2.6 mg) and a certain amount of Ligand Ligand 1-10 (0.03-0.04 mmol), adding a certain volume of toluene and internal standard substance n-decane, and stirring and complexing for 30 minutes by using a magneton to generate a catalytic complex of rhodium and the Ligand. Then, after connecting a gas pipeline and fully replacing, adding a certain proportion of plunger pump with metering function into the reaction kettle under the switching of two-position four-way valveThe concentration of the rhodium catalyst in the total solution is controlled to be about 159ppm by the liquefied MTO carbon four, and the mixture is uniformly stirred for 5 to 10 minutes at room temperature. After stirring uniformly, a mixed gas (1:1) of carbon monoxide and hydrogen is charged into the reaction device until the total pressure is 1.0MPa. The reaction kettle is heated to the required temperature (70 ℃) by a magnetic stirrer (heating kettle bottom) and an electric heating sleeve (heating kettle body), and the total pressure is kept constant at 1.0MPa by continuously supplying air during the reaction. After reacting for 2-4 hours, the reaction kettle is connected to a-40 ℃ cold jacket for cooling, after the kettle temperature is reduced to the normal temperature, an online sampling port is opened for sampling under the condition of not opening the kettle, and a Gas Chromatograph (GC) is used for measuring the normal-to-iso ratio (the ratio of n-valeraldehyde to 2-methylbutyraldehyde: l: b) after the online sampling port is diluted by chromatographic grade ethyl acetate. And after the kettle is opened, completely releasing the gas in the high-pressure reaction kettle in a fume hood, and sampling and weighing. The results are shown in Table 2.
TABLE 2
Claims (10)
1. A preparation method and application of a large steric hindrance oxaspiro compound are characterized in that: has the following synthetic route:
4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -biphenol and diphosphine compound synthesis route thereof:
Synthesis scheme 1:
Synthesis scheme 2:
Synthetic route3:
Wherein, the oxaspiro compounds represented by the general formula I can be racemates containing symmetrical or asymmetrical structures, and can also be compounds containing optical activity or chirality, R represents chlorophosphites containing biphenyl, methylene diphenyl, binaphthyl, benzoyloxy, o-phenyl or containing phenyl, naphthyl and aryl, and the like, and the structures are as follows:
2. a process for the preparation of a sterically hindered oxaspiro compound as claimed in claim 1, characterized in that: 3-methoxyphenol and 1,3-dichloro-2-propanol are subjected to nucleophilic substitution reaction to obtain 1,5-bis (3-methoxyphenoxy) -2-propanol (2); under the catalysis of protonic acid or Lewis acid, isobutene and protons are added to generate tert-butyl carbonium ions, and the tert-butyl carbonium ions are further subjected to alkylation reaction with a benzene ring on 3-methoxyphenol to obtain 2,4-di-tert-butyl-5-methoxyphenol (2 a or 2 c); 2,4-di-tert-butyl-5-methoxyphenol and 1,3-dichloro-2-propanol or 2,2-bis (chloromethyl) -1,3-dioxolane are subjected to nucleophilic substitution reaction to obtain 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -2-propanol (3 a) or 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -2-propyldioxolane (3 c);
the halogenating agent used in the nucleophilic substitution reaction may be, in addition to 1,3-dichloro-2-propanol or 2,2-bis (chloromethyl) -1,3-dioxolane: 1,3-difluoro-2-propanol, 1,3-dibromo-2-propanol, 1,3-diiodo-2-propanol, epichlorohydrin; or 2,2-bis (fluoromethyl) -1,3-dioxolane, 2,2-bis (bromomethyl) -1,3-dioxolane, 2,2-bis (iodomethyl) -1,3-dioxolane;
the protonic acid or Lewis acid used in the above reaction is one or more of organic acid or inorganic acid, and the organic acid is: formic acid, acetic acid, oxalic acid, dichloroacetic acid, trifluoroacetic acid, propionic acid, malonic acid, pyruvic acid, butyric acid, valeric acid, caproic acid, adipic acid, benzoic acid, p-nitrobenzoic acid, terephthalic acid, benzenesulfonic acid, fluorosulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and the like; inorganic acids such as: hydrobromic acid, hydrochloric acid, hydrofluoric acid, sulfurous acid, sulfuric acid, perchloric acid, phosphonic acid, pyrophosphoric acid, nitric acid, nitrous acid, chromic acid, fluoroantimonic acid, and the like; the alkylating reagent is any one of bromo-tert-butane, chloro-tert-butane, isobutene and tert-butanol; the reaction temperature is 80-140 ℃, and the reaction solvent is any one of benzene, toluene, p-xylene, o-xylene, chlorobenzene or dichlorobenzene.
3. A process for the preparation of a sterically hindered oxaspiro compound as claimed in claim 1, characterized in that: the intermediate 2 or 3a is subjected to chromium trioxide catalytic oxidation to obtain 1,5-bis (3-methoxyphenoxy) -acetone (3) or 2,4-di-tert-butyl-1,5-bis (3-methoxyphenoxy) -acetone (4 a);
the metal oxide used in the oxidation reaction is any one of chromium trioxide, chromic acid, potassium dichromate and sodium dichromate; the acid solution can be any one of concentrated sulfuric acid, phosphonic acid, hexafluorophosphonic acid, hypochlorous acid, chlorous acid, glacial acetic acid and peroxyacetic acid; the dosage of the metal oxide is 0.05 to 1 equivalent, the reaction solvent is acetone or water or a mixed solvent thereof, the proportion of the mixed solvent is between 50 and 70, and the reaction temperature is between 25 and 45 ℃.
4. A process for the preparation of a sterically hindered oxaspiro compound as claimed in claim 1, characterized in that: halogenating the intermediate 3 with bromine or N-bromosuccinimide to obtain 1,5-bis (2-bromo-3-methoxyphenoxy) -acetone (4); under the action of a dehydrating agent, the intermediate 4 or 4a or 3c is subjected to Friedel-crafts cyclization to obtain 4,4' -dibromo-7,7 ' -dimethoxy-1,1 ' -spirodihydrobenzofuran (5) or 4,4',6,6' -tetra-tert-butyl-7,7 ' -dimethoxy-1,1 ' -spirodihydrobenzofuran (5 a or 4 c);
the dosage of the bromine or the N-bromosuccinimide used in the halogenation reaction is 1 to 10 equivalents, the dosage of the pyridine is 2 to 20 equivalents, the reaction temperature is-20 to 40 ℃, the reaction time is 2 to 24 hours, and the reaction solvent is organic solvent such as diethyl ether, tetrahydrofuran, 1,4-dioxane, dichloromethane and the like;
the dehydrating agent used in the Friedel-crafts cyclization reaction is any one of polyphosphoric acid, concentrated sulfuric acid, acetic anhydride, methanesulfonic acid, benzoic acid, p-toluenesulfonic acid and anhydrous aluminum trichloride. The reaction solvent is any one of toluene, n-heptane, dichloromethane, trichloromethane and dichloroethane. The dosage of the dehydrating agent is 10 to 70 equivalent, the reaction temperature is 45 to 135 ℃, and the reaction time is 2 to 6 hours.
5. A process for the preparation of a sterically hindered oxaspiro compound as claimed in claim 1, characterized in that: the intermediate 5 is subjected to debromination reaction under the action of n-butyllithium to obtain 7,7 '-dimethoxy-1,1' -spirodihydrobenzofuran (6), the intermediate 6 or 5a or 4c is subjected to methyl protecting group removal under the action of a demethylating reagent to obtain 1,1 '-spirodihydrobenzofuran-7,7' -diphenol (7) or 4,4',6,6' -tetra-tert-butyl-1,1 '-spirodihydrobenzofuran-7,7' -diphenol ((rac) -O-SPINOL), and the intermediate 7 is subjected to alkylation reaction with isobutene to obtain racemic sterically hindered (rac) -O-SPINOL;
in the debromination reaction, the dosage of n-butyllithium is 2.5 to 10 equivalents, the reaction temperature is-78 to 5 ℃, the reaction time is 0.5 to 5 hours, and the reaction solvent is organic solvent such as diethyl ether, tetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether and the like;
the demethylating reagent used in the reaction is any one of boron tribromide, hydrobromic acid, aluminum trichloride, pyridine hydrochloride and sodium ethyl mercaptide. The dosage of the demethylating reagent is 2.0 to 5 equivalent, the reaction temperature is-78 to 25 ℃, and the reaction solvent is any one of dichloromethane, dichloroethane and trichloroethane.
6. A process for the preparation of a sterically hindered oxaspiro compound as claimed in claim 1, characterized in that:
sequentially adding (rac) -O-SPINOL and an organic solvent into a reaction container under the nitrogen atmosphere to obtain a first mixed solution; or sequentially adding (rac) -O-SPINOL and an organic solvent into the reaction container in the nitrogen atmosphere, dropwise adding n-butyllithium at low temperature, and heating to room temperature for reflux reaction after dropwise adding is finished to obtain a lithiated first mixed solution;
dropping biphenyl, methylene diphenyl, binaphthyl, benzoyloxy, o-phenyl, or a mixed solution of chlorophosphonites containing phenyl, naphthyl, aryl and the like and an acid-binding agent or an organic solution of the above chlorophosphonites into the first mixed solution or the lithiated first mixed solution at low temperature, reacting at room temperature after dropping, treating inorganic salt, and concentrating to obtain crude products of the oxaspiro compounds with large steric hindrance;
in the esterification reaction, the using amount of n-butyl lithium is 2-4 equivalents; the acid binding agent is any one of triethylamine, N-diisopropylethylamine and pyridine, and the dosage is 5-20 equivalent; the reaction temperature is-78-80 ℃, the reaction time is 12-48 hours, and the reaction solvent is any one of toluene, tetrahydrofuran, diethyl ether, 2-methyl tetrahydrofuran, methyl tert-butyl ether, isopropyl ether, anisole, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, butyl ether, cyclopentyl methyl ether or 1,4-dioxane.
7. A process for the preparation of a sterically hindered oxaspiro compound as claimed in claim 6, characterized in that: the solvent for recrystallization purification of the large steric hindrance oxaspiro compound is one or more of ethyl acetate, toluene, dichloromethane, ethanol, acetonitrile, petroleum ether, n-hexane and tetrahydrofuran.
8. Process for the preparation of sterically hindered oxaspiro compounds according to claims 1 and 6, characterized in that: the O-SPINOL may be (+ -) -O-SPINOL, (+) -O-SPINOL or (-) -O-SPINOL; the oxaspiro compound can be (+/-) -spiro diphosphonite, (+) -spiro diphosphonite or (-) -spiro diphosphonite compound, and the chiral O-SPINOL can realize efficient resolution by adopting proline, menthyl chloroformate or chiral phase transfer catalyst N-benzylcinchonine chloride as a resolution reagent.
9. A catalytic complex characterized by: the catalytic complex comprises a transition metal precursor (e.g., rh, pt, pd, ru, ir, etc.) and a racemic oxaspiro bisphosphonite ligand, including all ligands listed in formula I in claim 1 except for (R, S) -L12, (R, S) -L13, (R, S) -L17, and (R, S) -L31. In addition, the catalytic complex comprises a transition metal precursor (such as Rh, pt, pd, ru, ir, etc.) and a chiral oxaspiro bisphosphinite ligand comprising L1 to L31 as set forth in formula I in claim 1.
10. A process for the hydroformylation of olefins to produce linear aldehydes, characterized by: the preparation method comprises the step of reacting olefin with synthesis gas in the presence of the catalytic complex of claim 9 to obtain the linear aldehyde. The method can be realized according to the following process steps and parameters;
(1) Sequentially adding a racemic oxaspiro diphosphonite ligand and a rhodium catalyst in a certain proportion in a reaction device under the protection of inert gas, wherein the molar ratio of phosphine to rhodium is 1:1-5:1, and stirring and complexing for 30 minutes at room temperature under an organic solvent;
(2) Then, under the protection of inert gas, adding liquid ether with a certain proportion into the reaction kettle by using a plunger pump with a metering function to control the concentration of the rhodium catalyst to be about 50-200 ppm, and then uniformly stirring for 5-10 minutes at room temperature.
(3) After stirring uniformly, filling CO and H with a certain pressure into the reaction device 2 The pressure ratio of hydrogen to carbon monoxide is between 1:1 and 1:5, and the total pressure is between 0.5MPa and 1 MPa; stirring and reacting for 1-4 hours at the temperature of 40-100 ℃;
the post-ether carbon four and the MTO carbon four used in the hydroformylation reaction comprise the following components in percentage by mass: 0-30% of 1-butene, 0-70% of trans-2-butene, 0-40% of cis-2-butene, 0-30% of n-butane, 0-20% of isobutane and 0-10% of isobutene, wherein the total mass percentage of the 1-butene, the trans-2-butene, the cis-2-butene, the n-butane, the isobutane and the isobutene is 100%.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110565725.5A CN115385960A (en) | 2021-05-24 | 2021-05-24 | Preparation method and application of oxaspiro compound with large steric hindrance |
US17/725,853 US20220242891A1 (en) | 2021-04-26 | 2022-04-21 | Spiro-bisphosphorous compound, and preparation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110565725.5A CN115385960A (en) | 2021-05-24 | 2021-05-24 | Preparation method and application of oxaspiro compound with large steric hindrance |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115385960A true CN115385960A (en) | 2022-11-25 |
Family
ID=84113900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110565725.5A Pending CN115385960A (en) | 2021-04-26 | 2021-05-24 | Preparation method and application of oxaspiro compound with large steric hindrance |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115385960A (en) |
-
2021
- 2021-05-24 CN CN202110565725.5A patent/CN115385960A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhu et al. | “Click” post-synthetic modification of metal–organic frameworks with chiral functional adduct for heterogeneous asymmetric catalysis | |
CN108659046B (en) | Monophosphine ligand based on tetramethyl spiroindane skeleton, intermediate thereof, preparation method and application | |
CN111315755B (en) | High isomerism selectivity catalyst for hydroformylation of olefins | |
CN112010906B (en) | Bisphosphite and preparation method and application thereof | |
US4742178A (en) | Low pressure hydroformylation of dienes | |
CN113583045B (en) | Catalyst composition containing bidentate phosphine ligand and application thereof | |
CN105728046B (en) | A kind of ruthenium metal olefin metathesis catalyst and its methods for making and using same | |
Xu et al. | B (C 6 F 5) 3-Catalyzed formal (4+ 1)-annulation of ortho-quinone methides with diazoacetates: access to 2, 3-dihydrobenzofurans | |
CN112159313B (en) | Preparation method of large-steric-hindrance biphenol skeleton and phosphonite ligand thereof | |
CN115246767A (en) | Synthesis method of spiro diphenol with large steric hindrance and diphosphonite compound thereof | |
CN115385960A (en) | Preparation method and application of oxaspiro compound with large steric hindrance | |
CN111909209A (en) | Preparation method of biphenyl tetradentate phosphonite ligand | |
CN115246765B (en) | Preparation method and application of spiro diphenol and biphosphinate thereof | |
CN111484437A (en) | Method for introducing tertiary isopentenyl group to C3 position of indole | |
US8779164B2 (en) | Phosphine-based catalysts useful for the telomerization of butadiene | |
CN111875637B (en) | Phosphine ligand and synthesis method and application thereof | |
CN110997608B (en) | Dihydroxybiphenyl compound, bisphosphite compound, catalyst, method for producing aldehydes, and method for producing alcohols | |
US20220242891A1 (en) | Spiro-bisphosphorous compound, and preparation and application thereof | |
EP2726202A1 (en) | Method for the preparation of palladium(i) tri-tert-butylphosphine bromide dimer and process for its use in isomerization reactions | |
CN107827717B (en) | Preparation method of diglycerol monoalkyl ether formal | |
CN114644652A (en) | Preparation method of large steric hindrance biphenol compound and diphosphine ligand thereof | |
KR20210013703A (en) | Catalyst composition containing a combination of monophosphine and tetraphosphine ligand and hydroformylation process using the same | |
CN114149464B (en) | Ligand for polyketone polymerization catalyst and preparation method thereof | |
CN111484397B (en) | (2-hydroxyphenyl) (2,4, 6-trimethoxyphenyl) (phenyl) methane and synthesis method thereof | |
CN113877635B (en) | Iridium-based catalyst, preparation method thereof and hydroformylation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |